Portions of the funds will be made available to all 50 state health departments, six local health departments — Chicago, the District of Columbia, Houston, Los Angeles County, New York City and Philadelphia — and Puerto Rico. Funds will also support seven new regional laboratories strategically located in the Midwest, Northeast, Mid-Atlantic, Southeast, Mountain region, Central U.S. and the West with rapid diagnostic capabilities to detect emerging antibiotic resistant threats. The funds will become available to jurisdictions beginning Aug. 1.
To learn more about the regional labs click here.
Find more information on the funds from the CDC here.
More articles on infection control:
New yellow fever vaccine trials underway
Protein from breast milk reduces staph infection risk in premature infants
3 key risk factors for patient-to-patient transmission of resistant bacteria
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
